The study aims to provide high quality evidence for the use on hemin for prevention of acute attacks of porphyria. A separate study is in progress to evaluate the use of Panhematin for treatment of acute attacks of porphyria. Such studies have not been done previously for treating or preventing acute attacks with hemin. The lack of strong evidence for efficacy of hemin for treatment and prevention of attacks limits its availability for patients with acute porphyrias.